Would you like to learn more about the latest research and what is on the horizon in terms of treatments for Alzheimer's?
Join us on October 27 for a public lecture by Roger M Nitsch, CEO of the Swiss company behind the new drug.
When and where?
Wed 27 October at 7 pm in Kinepolis Leuven (Bondgenotenlaan, 200m from the station)
By who?
Roger M Nitsch, CEO and president of Neurimmune, the company behind aducanumab
For whom?
Everyone is welcome. The lecture will be in English. Admission is free, but registration is required.
Register here.
This lecture is supported by ‘Stichting Alzheimer Onderzoek’, the Belgian Foundation for Alzheimer Research.
Find out more here:
